Ira Pastor, ideaXme life sciences ambassador interviews Dr Alexander Titus Chief Strategy Officer (CSO) at the Advanced Regenerative Manufacturing Institute (ARMI).
Ira Pastor comments:
Advanced Regenerative Manufacturing (ARMI)
The Advanced Regenerative Manufacturing Institute (ARMI) is one of 14 institutes of the Manufacturing USA network, and is a member-driven, non-profit organization, whose mission is to make practical the large-scale manufacturing of engineered tissues and tissue-related technologies. BioFabUSA, created by ARMI, was established to lead the charge in large-scale manufacturing of engineered tissues and regenerative medicine research, turning foundational breakthroughs in the manufacture of engineered tissues and tissue-related technologies into life-changing possibilities for everyone. Dr. Alexander Titus is the Chief Strategy Officer (CSO) at the Advanced Regenerative Manufacturing Institute (ARMI) where he is part of the leadership team working to advance the U.S. regenerative manufacturing industry, as well as develop technologies for disaster preparedness.
Dr Alexander Titus’ Career
Dr. Titus’s career is focused on the intersection of technology and public benefit, with experience spanning the private and public sectors, as well as non-profits and academia. Prior to his role ARMI, Dr Titus was the inaugural Assistant Director for Biotechnology, within the Office of the CTO at the Department of Defense (DoD), where he was the Deputy Assistant Secretary of Defense-level senior executive in charge of the DoD’s enterprise strategy for biotechnology, where he led the team developing the biotechnology modernization roadmap for the DoD.
Dr. Titus joined the DoD from McKinsey & Company, where he was a management consultant and a member of the inaugural cohort of Defense & Security Specialists working with the national security community on high-priority issues related to organization effectiveness, leadership, and analytics. On the technical side, Dr Titus is a trained data scientist with an expertise at the intersection of AI and biology.
Dr Titus’ work with In-Q-Tel, B. Next group
Prior to consulting, Dr. Titus was a data scientist at the venture capital firm In-Q-Tel, as a member of their B.Next group, as well as a data scientist at Amazon on the Alexa AI team and at Dartmouth in the Geisel School of Medicine. Alexander holds a PhD in Quantitative Biomedical Sciences from the Guarini School of Graduate and Advanced Studies at Dartmouth, as well as a BS and BA in biochemistry and biology from the University of Puget Sound.
On this ideaXme episode we will hear from Dr. Titus about:
– His background – how he developed an interest in science, biology, biochemistry, quantitiave biomedicine, and a bit of his journey through academia, the military, and the private sector – The background of the Manufacturing USA network – The background of the Advanced Regenerative Manufacturing Institute (ARMI) and the BioFabUSA initiative – BioFabUSA’s five thrust areas and support technologies related to (1) Cell Selection, Culture and Scale-up, (2) Biomaterial Selection and Scale-up; (3) Tissue Process Automation and Monitoring; (4) Tissue Maturing Technologies and (5) Tissue Preservation and Transport – Visions for the tissues / organs / limbs bio-factory of the future – His work in bio-security and bio-defense
Credits: Ira Pastor, ideaXme ambassador interview.
This interview is in American English.
If you enjoyed this interview please check out our interview with Dr Tara O’Toole Executive Vice President and Senior Fellow In-Q-Tel.
Follow ideaXme on Twitter:@ideaxm On Instagram:@ideaxme
To discuss collaboration and/or partnerships please contact the founder of ideaXme: [email protected]
Find ideaXme across the internet including on iTunes, SoundCloud,Radio Public,TuneIn Radio,I Heart Radio, Google Podcasts, Spotify, Amazon Podcasts and more. ideaXme is a global podcast, creator series and mentor programme. Our mission: Move the human story forward!™ ideaXme Ltd.
